The manifold actions of neurotensin: a first synthesis.
D000662:Amphetamines / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology; D001812:Blood-Brain Barrier; D001831:Body Temperature / Q000187:drug effects; D002421:Caudate Nucleus / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D004298:Dopamine / Q000502:physiology; D004347:Drug Interactions; D006801:Humans; D009043:Motor Activity / Q000187:drug effects; D009496:Neurotensin / Q000008:administration & dosage / Q000494:pharmacology; D009619:Nociceptors / Q000187:drug effects; D009714:Nucleus Accumbens / Q000187:drug effects; D011954:Receptors, Dopamine / Q000187:drug effects; D013239:Stereotyped Behavior / Q000187:drug effects; D013681:Tegmentum Mesencephali / Q000187:drug effects; D013973:Thyrotropin-Releasing Hormone / Q000494:pharmacology
D000662:Amphetamines; D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D009496:Neurotensin; D013973:Thyrotropin-Releasing Hormone; D004298:Dopamine